Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 14/20 | 0.57 |
| ▸ | TFPI | P10646 | 1/20 | 0.54 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.54 |
| ▸ | BACE1 | P56817 | 1/20 | 0.54 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31369291 | 0.95 | KISS1R (0.61) | KISS1RTFPIIL23RBACE1BACE2 | |
| SCHEMBL29520890 | 0.91 | BACE1 (0.57) | KISS1RBACE1BACE2NPY1RNPY2R | |
| SCHEMBL30974431 | 0.90 | KISS1R (0.53) | KISS1RTFPIIL23RBACE1BACE2 | |
| SCHEMBL30974094 | 0.90 | KISS1R (0.53) | KISS1RTFPIIL23RBACE1BACE2 | |
| SCHEMBL30974311 | 0.88 | KISS1R (0.58) | KISS1RBACE1NPY1RNPY2RNPY4R | |
| SCHEMBL29778025 | 0.87 | NTSR2 (0.57) | KISS1RBACE1BACE2 | |
| SCHEMBL29521063 | 0.87 | NTSR2 (0.57) | KISS1RBACE1BACE2 | |
| SCHEMBL17176533 | 0.87 | TFPI (0.62) | KISS1RTFPIIL23RNPY2R | |
| SCHEMBL30512662 | 0.86 | NPY4R (0.62) | KISS1RBACE1BACE2NPY1RNPY2R | |
| SCHEMBL29961427 | 0.86 | NPY1R (0.74) | BACE1BACE2NPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025058511-A1 | ACYLTRANSFERASE-CATALYSED MODIFICATION OF PEPTIDES | ENDOPROTEASE SERVICES B.V. (NL) | 2025-03-20 | — | — | WO | disclosed |